Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Westfälische Wilhelms-Universität Münster is active in the Biotechnology & Pharmaceuticals technology area with 2 pending office actions. This level of activity indicates an ongoing effort to secure patent protection for the institution's research. The 2 pending office actions represent the current focus of the university's intellectual property strategy in this sector.
The prosecution is distributed across 2 distinct art units and involves 2 distinct examiners. This distribution suggests that the university's 2 pending office actions cover different technical sub-fields within Biotechnology & Pharmaceuticals. For a practitioner, having 2 distinct examiners means that the prosecution is not limited to a single viewpoint within the patent office.
SZPERKA, MICHAEL EDWARD is the busiest examiner for the portfolio, with a busiest examiner pending count of 1. This examiner is responsible for 1 of the 2 pending office actions. The presence of SZPERKA, MICHAEL EDWARD as the busiest examiner with a count of 1 indicates that the 2 pending office actions are shared across the 2 distinct examiners currently assigned to the university's matters.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BATES, KEENAN ALEXANDER | 1 | 45.5% | +79.5% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17613927 | RAPID AND DETERMINISTIC GENERATION OF MICROGLIA FROM HUMAN PLURIPOTENT STEM CELLS | BATES, KEENAN ALEXANDER | — |
| Art Unit | Apps |
|---|---|
| 1631 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17613927 | RAPID AND DETERMINISTIC GENERATION OF MICROGLIA FROM HUMAN PLURIPOTENT STEM CELLS | BATES, KEENAN ALEXANDER | 1631 | §103 | Final Rejection | — | Pending | Nov 23, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial